Insilico discovery of novel Phosphodiesterase 4 (PDE4) inhibitors for the treatment of psoriasis: Insights from computer aided drug design approaches.

Psoriasis is chronic immune-mediated inflammatory disorder characterized by various comorbidities, erythematous plaques with silvery scale which can lead to psoriatic arthritis.The phosphodiesterase 4 Play Yards (PDE4) protein is a potential drug target to control Psoriasis.In the current study, pharmacophore-based virtual screening of Diversity li

read more